NCT05558085

Brief Summary

The goal of this integrated project is to assess whether EFNEP is a cost-effective nutrition education intervention that generates sustained improvement in chronic disease biomarkers. This project will be unique in its use of objective biomarkers, instead of self-reported behaviors, to quantify the economic benefits generated by EFNEP through chronic disease prevention. A paired location untreated control group quasi-experimental design will be employed, with biomarkers (BMI, blood pressure, HbA1c) measured for 500 adults across four representative state EFNEP programs (CO, FL, MD, WA). Biomarkers will be measured pre-EFNEP, 6-months-post-EFNEP and 1-year-post-EFNEP. Analytical techniques will include cost-benefit, bivariate, and multivariate analyses.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

September 26, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 28, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 12, 2023

Status Verified

April 1, 2023

Enrollment Period

2.3 years

First QC Date

September 23, 2022

Last Update Submit

April 11, 2023

Conditions

Keywords

DietNutrition EducationBiomarkerCost-benefit analysisEFNEP

Outcome Measures

Primary Outcomes (8)

  • Change in Height from Baseline to 6 Months Post Intervention

    Height (m) is measured using a portable stadiometer.

    Change in height measurement from baseline to 6 months post intervention

  • Change in Height from Baseline to 12 Months Post Intervention

    Height (m) is measured using a portable stadiometer.

    Change in height measurement from baseline to 12 months post intervention

  • Change in Weight from Baseline to 6 Months Post Intervention

    Weight (kg) is measured using a portable scale.

    Change in weight measurement from baseline to 6 months post intervention

  • Change in Weight from Baseline to 12 Months Post Intervention

    Weight (kg) is measured using a portable scale.

    Change in weight measurement from baseline to 12 months post intervention

  • Change in Systolic and Diastolic Blood Pressure from Baseline to 6 Months Post Intervention

    Systolic and Diastolic blood pressure are measured using an OMRON Silver blood pressure monitor

    Change in Systolic and Diastolic blood pressure measurements from baseline to 6 months post intervention

  • Change in Systolic and Diastolic Blood Pressure from Baseline to 12 Months Post Intervention

    Systolic and Diastolic blood pressure are measured using an OMRON Silver blood pressure monitor

    Change in Systolic and Diastolic blood pressure measurements from baseline to 12 months post intervention

  • Change in HbA1c from Baseline to 6 Months Post Intervention

    HbA1c is measured using A1CNow monitor.

    Change in HbA1c measurement from baseline to 6 months post intervention

  • Change in HbA1c from Baseline to 12 Months Post Intervention

    HbA1c is measured using A1CNow monitor.

    Change in HbA1c measurement from baseline to 12 months post intervention

Secondary Outcomes (11)

  • Change in EFNEP Adult Questionnaire Responses Baseline to 6 Months Post Intervention

    Change in EFNEP Adult Questionnaire Responses Baseline to 6 Months Post Intervention

  • Change in EFNEP Adult Questionnaire Responses Baseline to 12 Months Post Intervention

    Change in EFNEP Adult Questionnaire Responses Baseline to 12 Months Post Intervention

  • Change in 24-Hour Dietary Recalls Baseline to 6 Months Post Intervention

    Change in 24-Hour Dietary Recalls Baseline to 6 Months Post Intervention

  • Change in 24-Hour Dietary Recalls Baseline to 12 Months Post Intervention

    Change in 24-Hour Dietary Recalls Baseline to 12 Months Post Intervention

  • Participant Demographics Baseline

    Baseline.

  • +6 more secondary outcomes

Study Arms (2)

EFNEP Group

EXPERIMENTAL

Subjects will receive the EFNEP Eat Smart Being Active class series.

Behavioral: Expanded Food and Nutrition Education Program (EFNEP)

Control Group

NO INTERVENTION

Subjects will receive no EFNEP intervention.

Interventions

Subjects will participate in nine hands-on EFNEP lessons to teach nutrition, healthy lifestyle choices, physical activity, food preparation, food safety, and food resource management.

EFNEP Group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Free-Living
  • Speaks and understands English and/or Spanish
  • Income at or below 185% of the Federal Poverty Line

You may not qualify if:

  • Being pregnant, nursing, and/or less than 9-months postpartum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Colorado State University

Fort Collins, Colorado, 80523, United States

NOT YET RECRUITING

University of Florida

Gainesville, Florida, 32611, United States

RECRUITING

University of Maryland

College Park, Maryland, 20742, United States

RECRUITING

Washington State University

Pullman, Washington, 99164, United States

RECRUITING

MeSH Terms

Conditions

Chronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Andrea M Leschewski, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2022

First Posted

September 28, 2022

Study Start

September 26, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 12, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

Deidentified participant data will be made available on South Dakota State University's Open Access Institutional Repository, Open PRAIRIE.

Locations